The Times of IsraelHealth
Israeli Researchers Find Promising Drug Combination for LADA Diabetes in Mice
Summarized from The Times of Israel by baba
CenterNeutral tone
Israeli researchers have developed a promising treatment for LADA diabetes using a combination of three existing drugs, achieving remission in 30% of mice. The therapy, combining GABA, sitagliptin, and omeprazole, restored normal blood sugar levels and insulin production in the treated animals. Researchers also identified RNA biomarkers that predict treatment response, paving the way for personalized medicine. The team plans to move to human clinical trials, as the drugs are already FDA-approved.
The story in 5 lines · by baba
- Israeli researchers achieved 30% remission in mice with LADA diabetes using a three-drug combination.
- The experimental therapy combines GABA, sitagliptin, and omeprazole, restoring normal blood sugar.
- Specific RNA biomarkers were identified to predict which mice would respond to the treatment.
- LADA, or 'Type 1.5 diabetes,' is often misdiagnosed but accounts for 9.1% of global diabetes cases.
- The research team plans human clinical trials, as the drugs are already FDA-approved.
The Times of Israel publishes in English. The key points are summarized above. Read The Times of Israel’s full report from the link at the top of the page.